RLAY (STOCKS)
Relay Therapeutics, Inc. Common Stock
$8.780000
-0.370000 (-4.04%)
Prev close: $9.150000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Sanjiv K. Patel
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,528.70M
- Employees
- 197
- P/E (TTM)
- -5.03
- P/B (TTM)
- 2.50
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
8
Strong Buy
9
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.43 | $-0.42 | -0.0062 | -1.46% |
|
Jun 2025 (Q2)
|
$-0.41 | $-0.50 | +0.0914 | +18.23% |
|
Mar 2025 (Q1)
|
$-0.46 | $-0.50 | +0.0378 | +7.59% |
|
Dec 2024 (Q4)
|
$-0.45 | $-0.57 | +0.1230 | +21.47% |
Financial Statements
| Revenues | $8.36M |
| Benefits Costs and Expenses | $0.00 |
| Costs And Expenses | $335.44M |
| Operating Expenses | $335.44M |
| Operating Income/Loss | -$327.09M |
| Income/Loss From Continuing Operations After Tax | -$297.59M |
| Income/Loss From Continuing Operations Before Tax | $8.36M |
| Net Income/Loss | -$297.59M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$297.59M |
| Net Income/Loss Available To Common Stockholders, Basic | -$297.59M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.72 |
| Diluted Earnings Per Share | -$1.72 |
| Basic Average Shares | 179,190,005 |
| Assets | $670.00M |
| Current Assets | $624.01M |
| Prepaid Expenses | $23.84M |
| Other Current Assets | $600.18M |
| Noncurrent Assets | $45.99M |
| Fixed Assets | $2.36M |
| Other Non-current Assets | $43.63M |
| Liabilities | $62.29M |
| Current Liabilities | $32.61M |
| Accounts Payable | $2.75M |
| Other Current Liabilities | $29.85M |
| Noncurrent Liabilities | $29.69M |
| Equity | $607.71M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $607.71M |
| Liabilities And Equity | $670.00M |
| Net Cash Flow From Operating Activities | -$248.46M |
| Net Cash Flow From Operating Activities, Continuing | -$248.46M |
| Net Cash Flow From Investing Activities | $186.33M |
| Net Cash Flow From Investing Activities, Continuing | $186.33M |
| Net Cash Flow From Financing Activities | $1.47M |
| Net Cash Flow From Financing Activities, Continuing | $1.47M |
| Net Cash Flow | -$60.65M |
| Net Cash Flow, Continuing | -$60.65M |
| Comprehensive Income/Loss | -$299.61M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$299.61M |
| Other Comprehensive Income/Loss | -$2.02M |